ProCE Banner Activity

CE / CME

Hereditary Angioedema: Enhancing Patient Quality of Life Through Individualized Treatment and Improved Access to Care

Virtual Roundtable

Hereditary angioedema (HAE) is a is a rare but potentially life-threatening disorder that affects both pediatric and adult patients. The unpredictable nature and severity of HAE attacks negatively impacts patients’ physical functioning and quality of life. In recent years, the availability of new and effective medications for treating HAE has significantly improved clinical outcomes, including increasing the number of attack-free days. Tune in to this dynamic roundtable webcast as specialist and primary care clinicians discuss key issues in the management of HAE and strategies to successfully transition pediatric patients to adult care.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Released: October 31, 2022

Expiration: October 30, 2023

Begin Activity

Share

Faculty

Chrystal Lewis

Chrystal Lewis, PhD, RN

Nurse Scientist
Office of Research and Patient Care Services
Stanford Health Care
Menlo Park, California

Marc Riedl

Marc Riedl, MD, MS

Professor
Clinical Director
US HAEA Angioedema Center
University of California, San Diego
La Jolla, California

Susan Tiso

Susan Tiso, DNP, FNP-BC

Consultant; Retired Clinical Professor
Sue & Bill Gross School of Nursing
Family Nurse Practitioner
Department of Family Medicine
University of California, Irvine
Irvine, California

Provided by

ProCE Banner
ProCE Banner
ProCE Banner

Supporters

This activity is supported by educational grants from

BioCryst Pharmaceuticals, Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Target Audience

NPs and PAs in allergy, immunology, and primary care 

Disclosure

All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Faculty Disclosure

Chrystal Lewis, PhD, RN: consultant/advisor/speaker: Pharming.

Marc Riedl, MD, MS: researcher: Biocryst, CSL Behring, Ionis, Klavista, Pharvaris, Takeda; consultant/advisor/speaker: Astria, Biocryst, Biomarin, CSL Behring, Cycle Pharma, Ipsen, Klavista, Ono Pharma, Pfizer, Pharming, Pharvaris, RegenexBio, Spark, Takeda.

Susan Tiso, DNP, APRN, FNP-BC, has no relevant financial relationships to disclose.

Planner/Manager Text

None of the members of the Planning Committee or PACE staff have any relevant relationships to disclose.

CME Info

Participants wishing to earn CE/CME credit must:

  • View the content in its entirety
  • Relate the content material to the learning objectives
  • Complete the evaluation form

The estimated time to complete this activity is 1.00 hour.

Release date: October 31, 2022
Expiration date: October 30, 2023

Format

Video Rountable

Accreditation

NAPNAP CE Contact Hours Designation

This program is accredited for 1.0 NAPNAP CE contact hours of which 1.0 contain pharmacology (Rx) content, per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines.

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit

AAPA Credit Designation

Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until October 30, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Amanda Michaud, PA-C, AE-C, Family Allergy Consultants, Jacksonville, Florida

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.